ScholarIQanswers from OpenAlex & ORCID
Jean‐Jacques Kiladjian
ResearcherPublications, citations & collaboration network
Jean‐Jacques Kiladjian is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jean‐Jacques Kiladjian have?
ScholarIQindexed works
Jean‐Jacques Kiladjian has 750 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jean‐Jacques Kiladjian have?
ScholarIQcitation count
Jean‐Jacques Kiladjian has 28,595 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jean‐Jacques Kiladjian?
ScholarIQh-index
Jean‐Jacques Kiladjian has an h-index of 70 in OpenAlex.
What is the i10-index of Jean‐Jacques Kiladjian?
ScholarIQi10-index
Jean‐Jacques Kiladjian has an i10-index of 267 in OpenAlex.
What is the ORCID of Jean‐Jacques Kiladjian?
ScholarIQorcid
The ORCID for Jean‐Jacques Kiladjian is on the source record.
What is the OpenAlex record for Jean‐Jacques Kiladjian?
ScholarIQopenalex
The OpenAlex for Jean‐Jacques Kiladjian is on the source record.
What are the most-cited papers on Jean‐Jacques Kiladjian?
ScholarIQmost cited works
Baveno VII – Renewing consensus in portal hypertension
Roberto de Franchis, Jaime Bosch, Guadalupe García–Tsao, Thomas Reiberger, Cristina Ripoll, Juan G. Abraldeṣ, Agustı́n Albillos, Anna Baiges, Jasmohan S. Bajaj, Rafael Bañares, Marta Barrufet, Lina Benajiba, Annalisa Berzigotti, Christophe Bureau, Vincenza Calvaruso, Andrés Cárdenas, Gennaro D’Amico, Andrea De Gottardi, Alessandra Dell’Era, Àngels Escorsell, Jonathan Fallowfield, Héctor Ferral, Sven Francque, Ron C. Gaba, Juan Carlos García‐Pagán, Joan Genescà, Susana Rodrigues, Jordi Gracia‐Sancho, Guogong Han, Virginia Hernández–Gea, Jidong Jia, Jean‐Jacques Kiladjian, Aleksander Krag, Wim Laleman, Vincenzo La Mura, Sabela Lens, Xuefeng Luo, Mattias Mandorfer, Sarwa Darwish Murad, Valérie Paradis, David Patch, Salvatore Piano, Massimo Pinzani, Aurélie Plessier, Massimo Primignani, Bogdan Procopeț, Pierre‐Emmanuel Rautou, Marika Rudler, Shiv Kumar Sarin, Filippo Schepis, Marco Senzolo, Vijay H. Shah, Akash Shukla, Puneeta Tandon, Luís Téllez, Dominique Thabut, Maja Thiele, Jonel Trebicka, Dhiraj Tripathi, Emmanouil Tsochatzis, Laura Turco, Fanny Turón, Dominique Valla, Càndid Villanueva, Ian R. Wanless, Hitoshi Yoshiji
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
Peter Hillmen, Jeff Szer, Ilene C. Weitz, Alexander Röth, Britta Höchsmann, Jens Panse, Kensuke Usuki, Morag Griffin, Jean‐Jacques Kiladjian, Carlos de Castro, Hisakazu Nishimori, Lisa Tan, Mohamed Hamdani, Pascal Deschatelets, Cedric Francois, F Grossi, Temitayo Ajayi, Antonio M. Risitano, Régis Peffault de la Tour
SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis
Ruben A. Mesa, Jean‐Jacques Kiladjian, John Catalano, Timothy Devos, Miklós Egyed, Andrzei Hellmann, Donal P. McLornan, Kazuya Shimoda, Elliott F. Winton, Wei Deng, Ronald L. Dubowy, Julia D. Maltzman, Francisco Cervantes, Jason Gotlib
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis
Alessandro M. Vannucchi, H. Kantarjian, Jean‐Jacques Kiladjian, Jason Gotlib, F. Cervantes, Ruben A. Mesa, Nicholas J. Sarlis, Wei Peng, V. Sandor, P. Gopalakrishna, Abdel Hmissi, Viktoriya Stalbovskaya, Vikas Gupta, Claire Harrison, Srđan Verstovšek, on behalf of the COMFORT Investigators